To include your compound in the COVID-19 Resource Center, submit it here.

Pyridorin pyridoxamine: Phase I data; Phase II ongoing

In 2 placebo-controlled, double-blind, dose-escalating Phase I trials in 24

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE